Clin2
NCT07218549Possibly a fitNot yet recruiting

Study of psychoactive substances in people with past opioid use

Opioid UseSubstance Use DisordersOpioid Analgesia

Treatments studied

Part of Mental health clinical trials.

This trial tests how safe certain psychoactive substances are and what effects they have in people who have used opioids in the past but are not currently dependent on them. It aims to gather information that could help future treatment options.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
72 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are between 18 and 55 years old and speak English.
  • You have used opioids for fun at least 10 times in the past year and at least once in the last 12 weeks.
  • You are generally healthy based on a medical checkup and lab tests.
  • You are not currently pregnant, breastfeeding, or trying to become pregnant, and you use effective birth control if needed.
  • You do not have a current or past diagnosis of opioid use disorder or another substance use disorder (except marijuana or nicotine).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07338084Not yet recruiting
A study on opioids and their effects on the body

This study looks at how certain pain medicines (opioids) affect your body. It may help doctors understand how to better manage pain and side effects.

Košice
NCT05846451Recruiting· Early Phase 1
Study of how kratom and oxycodone interact in healthy adults

This early study tests how kratom can change the body’s handling of oxycodone (a prescription opioid) and how safe and measurable the effects are. It may help researchers understand drug interactions, especially for people who have used kratom and opioids before.

Spokane, Washington
NCT07204171Not yet recruiting· Phase 1
Study of oral MG001 in healthy adults with recent opioid use

This trial tests an oral medication called MG001 in healthy adults who have used oral opioids recently, to see how safe it is. It may help researchers understand if this new treatment could one day help with opioid-related conditions.

Overland Park, Kansas
NCT06089980Recruiting
Kratom product study for regular users

This study watches how regular kratom users react to their own kratom product. It aims to learn more about kratom's effects in real-world settings.

Baltimore, Maryland
NCT06021548Recruiting
Opioid addiction markers study

This study looks at physical, psychological, and social factors that may be linked to opioid addiction. It aims to better understand addiction to help improve future treatments.

Bron
NCT06786325Recruiting· Phase 2
Psilocybin treatment study for opioid use disorder

This trial tests whether psilocybin can help people recovering from opioid use disorder while living at a residential treatment center. If you are already taking buprenorphine/naloxone (Suboxone), methadone, or have received Sublocade, this study may be an option for you.

Philadelphia, Pennsylvania

Hear when a new Opioid Use trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.